Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

Koforidua, July 01, GNA – A Report by Ghana HIV and AIDS Network (GHANET), as part of its Community HIV self-testing project, ...

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

A line from Trump’s speech to Congress had ripple effects on health research funding for everything from HIV to asthma to ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...

The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...

The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.

Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...

Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...